Abstract: An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastral diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alpecia, irritable bowel syndrome, sleep disorders, dermatitides, schizophrenia, pain, etc.

Abstract: The present invention relates to a compound of the formula (I): wherein Az is a group comprising a monocyclic azole or a bicyclic aromatic ring of the same or different fused azoles; T, U, V and W are independently methine or nitrogen, said methine being optionally substituted by a substituent, and at least two of T, U, V and W are said methine groups; and X is nitrogen or methine. The compounds of the present invention are useful as agents for the treatment of various kinds of diseases related to NPY, for example, cardiovascular disorders, nervous system disorders, genitative diseases, metabolic diseases, genital or reproductive disorders, gastrointestinal disorders, respiratory disorders, inflammatory diseases or glaucoma, and the like.

Abstract: The present invention provides thieno[2,3-C]pyridine derivatives, pharmaceutical compositions comprising the thieno[2,3-C]pyridine derivatives, and methods of use thereof. The compounds capable of inhibiting glycosaminoglycan (GAG) interactions with effector cell adhesion molecules (ECAM) are useful for treating diseases and disorders mediated by GAG-ECAMs interactions, particularly inflammatory and autoimmune diseases, viral diseases, cancer, and amyloid disorders.

Abstract: The invention relates to novel indole derivatives of the general formula 1, to their preparation and to their use as medicaments, in particular for treating tumors

Abstract: It has now been found that certain novel N-(substituted aryl)-4-(disubstituted methyl)piperidine and pyridine derivatives have provided unexpected insecticidal activity. These compounds are represented by formula (I): wherein m, n, q, r, and s are independently selected from 0 or 1; and p is 0, 1, 2, or 3; A is CH or N; and B, D, E, R, R1, R2, R3, R4, R5, R6, R7 and R8 are fully described herein. In addition, compositions comprising an insecticidally effective amount of at least one compound of formula I, and optionally, an effective amount of at least one of a second compound, with at least one insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to a locus where insects are present or are expected to be present.

Abstract: Compounds having NR2B selective NMDA receptor antagonist activity are disclosed of the formula (I) wherein two of the neighboring R1, R2, R3 and R4 groups form an oxo-oxazolidine ring fused to the benzene ring of the indole nucleus, and the other two of R1, R2, R3 and R4 groups are hydrogen atoms, R5 and R6 together with the nitrogen between them form a saturated or unsaturated, 4-6 membered heterocyclic ring, which is substituted by phenoxy, phenyl-(C1-C4 alkyl), phenyl-(C1-C4 alkoxy), phenoxy-(C1-C4 alkyl), or benzoyl, optionally substituted on the aromatic ring by one or more halogen atoms, cyano or hydroxy groups, C1-C4 alkyl or C1-C4 alkoxy groups, X is NH—, Y is a —CH— group, or pharmaceutically acceptable salts thereof formed with acids or bases.

Abstract: Provided herein are cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals.

Abstract: Disclosed is a compound having the formula: pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and solvates of this invention are useful as LXR agonists.

Abstract: The benzene sulfonic acid salts of pramipexole have moderate water solubility and are useful pharmaceutical active agents.

Abstract: This invention provides compounds of the formula: wherein A?, X and Y are defined in the specification. These compounds are useful as antibacterial agents.

Abstract: The present invention relates to a compound of the formula I wherein J1, J2, R0, R1, R2, Q, V, G and M are as defined herein. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

Abstract: The present invention relates to adenosine A3? receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and theirs salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

Abstract: This invention is in the area of phenylindoles that are useful for the treatment of HIV infection, and, in particular, phenylindoles that exhibit significant activity against resistant strains of HIV. The phenylindoles have at least two substituents other than hydrogen on the benzo ring of the indole function, preferably at the 4? and 5?, 5? and 6? or the 5? and 7? positions, optionally in combination with disubstitution at positions 3? and 5? on the phenyl ring of the compound, and carboxamide containing moieties at position-2 on the indole group of the compound. Methyl is a preferred group for substitution on the phenyl ring. Preferred substituents for the benzo ring of the indole function include but are not limited to chlorine, fluorine, bromine, iodine, CF3, methoxy, CN, and NO2.

Abstract: The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula: useful as inhibitors of PHEX. These derivatives are useful for promoting generation of bone mass and treating or preventing diseases or conditions associated with a phosphate metabolism defect. Methods for preparation and intermediates are also disclosed.

Abstract: The present invention relates to compounds of formula I: or pharmaceutically acceptable salts thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.

Abstract: A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.

Abstract: The present invention relates to compounds of the general formula (II) and salts and physiologically functional derivatives thereof, for the use as a medicament.

Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof are provided: wherein each of R1, R2, R3, R4, y, m, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.

Abstract: Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Mannich base compound, or a derivative or modified compound, is employed which is capable of selectively inhibiting Jak3 while affecting other protein tyrosine kinase activities to a lesser extent or not at all, to provide beneficial effects such as mitigation of transplant rejection and alleviation of allergic responses with fewer side effects than with conventional immunosuppressive agents.

Abstract: Disclosed herein is the cosmetic use, as a desquamating agent, of at least one (dihydro)jasmonic acid derivative of a given formula. Further disclosed herein is a cosmetic method for smoothing the visible and/or tactile irregularities of the skin surface, for example, for smoothing wrinkles and fine lines and/or skin spots and/or smoothing the skin, comprising topically applying, to the skin, a composition comprising, in a physiologically acceptable medium, at least one (dihydro)jasmonic acid derivative and glycerine. Other embodiments disclosed herein are novel (dihydro)jasmonic acid derivatives.

Abstract: The present invention relates to novel N?-cyano-N-methylimidamide derivatives of the general formula (I) in which n represents 2, 3, 4 or 5, R represents optionally halogen-substituted C1-C4-alkyl, and X represents halogen, where the substituents X may in each case be identical or different, to processes for their preparation and to their use as pesticides.

Abstract: A method for controlling body fat in a human or nonhuman animal includes the step of reducing lipoxygenase activity in an animal. Lipoxygenase activity can be reduced by reducing the enzyme activity or by lowering the enzyme level. Reduced lipoxygenase activity correlates with reduced cell-associated LPL activity and with reduced cellular triacylglyceride level.

Abstract: The invention is directed, in part, to stable compositions of suspended carbon nanotubes, methods of making them, and uses thereof. The invention provides methods of producing high and low concentrations of highly dispersed carbon nanotubes suspended in a liquid. The carbon nanotube suspensions are of use in generating products with improved strength, weight, strength to weight ratio, electrical and thermal versatility, radiation shielding, capacitance, dielectric properties, selective ion flow, catalytic activity and biological applications. The invention provides for industrial processing of materials comprising carbon nanotubes such as, but not limited to, fibers, films, synthetic membranes, coatings, drug delivery systems, and molecular circuitry components.

Abstract: A dispersion of pyrogenically produced cerium oxide, which does not contain any particles larger than 1 ?m, is produced by dispersing a pyrogenically produced cerium oxide in water by means of a dissolver, centrifuging it, separating the supernatant from the bottom product, and again dispersing the supernatant by means of ultrasound. The dispersion can be used for chemical-mechanical polishing (CMP).

Abstract: In a process for forming a methane-enriched fuel, a hydrocarbon feedstock that includes hydrocarbons having molecular weights greater than that of methane (CH4) is mixed with an oxidizable gaseous reactant that includes water (H2O) and is free of molecular oxygen (O2). The mixture, which has a H2O/total hydrocarbon (H2O/C) ratio of less than about 1, is heated to an elevated temperature in the presence of a catalyst to form a methane-enriched pre-reformate product. At least a portion of the feedstock hydrocarbons having molecular weights greater than that of methane is converted to methane (CH4) in the process.

Abstract: A composition is provided and a method of using the same to form a pattern on a substrate using imprint lithography employing dark-field polymerization is disclosed. The composition includes a polymerizable bisvinylether and an initiator that produces an acid in response to radiation.

Abstract: The present invention relates to a light curable material comprising a splayed layered material, at least one aqueous dispersible polymerizer, and at least one aqueous soluble N-oxyazinium compound, wherein the polymerizer polymerizes upon exposure to light. The present invention also includes a method for curing a material comprising providing layered material, splaying the layered material, combining the splayed layered material with a polymerizer and an aqueous soluble N-oxyazinium compound, and subjecting the combination to light for a period of time sufficient to effect the polymerization of the polymerizer.

Abstract: Radiation curable ink compositions that include a curable component having a functionality that is greater than two, is present in the ink composition in an amount greater than 30 percent by weight, and has a molecular weight in the range of about 400 g/mole to about 10,000 g/mole; a component that has a functionality that is less than or equal to 2; and an initiator component. A solvent component, pigment, a surface tension modifier and other materials also can be included. The radiation curable inks are employed in ink jet printers and are particularly suited for use in printing on large-scale substrates. The printed images described herein have good adhesion to polymeric substrates such as styrene-based, polycarbonates, polyolefins, polyethylene terephthalate glycol ester, acrylic and others.

Abstract: A cationically curable composition for dental use containing a cationic polymerization initiator (I) and cationically polymerizable monomers (II), the cationically polymerizable monomers (II) containing an oxetane compound and an epoxy compound or an alkenyl ether compound at a ratio of amounts that satisfy the conditions expressed by the following formula, (a×A):(b×B)=91:9 to 45:55 wherein A is a mol number of the oxetane compound, “a” is an average number of the oxetane functional group contained in one molecule of the oxetane compound, B is a mol number of the epoxy compound or the alkenyl ether compound, and “b” is an average number of the epoxy functional group contained in one molecule of the epoxy compound or an average number of the alkenyl ether functional group contained in one molecule of the alkenyl ether compound.

Abstract: The invention relates to a marking liquid which contains a polymer dispersion with particles which are colored with marking agent, optionally further dyes and marking agents, one or more salts of a polyvalent, in particular bi- or trivalent cation, water and optionally moisture retaining agents and further usual additives, wherein the polymer forming the polymer particles is selected from the group of polyesters, polyester amides, polymers and copolymers based on acrylate or methacrylate with a proportion of free carboxylic acid groups of less than 10% by weight, melamine-formaldehyde-sulfonamide resins and mixtures thereof.

Abstract: An ink includes a jettable vehicle, a plurality of pigment solids dispersed in the jettable vehicle, and a styrene-maleimide copolymer dispersed in the jettable vehicle. Additionally, a method of rapidly printing an ink-jet image including ink-jetting an ink-jet ink onto a media substrate at a firing frequency from 12 kHz to 25 kHz, wherein the ink-jet ink includes a jettable vehicle, a plurality of non-acid-functionalized pigment solids dispersed in the jettable vehicle, and a styerene-maleimide copolymer dispersed in the jettable vehicle.

Abstract: The invention relates to pigment preparations in granulate form, containing one or more resins, one or more effect pigments and optionally, additives. The granulates are characterized in that they contain 3 to 10 wt. % water or a, solvent or solvent mixture with a vapor pressure of 0.001 to 40 hPa at 20° C.

Abstract: A rubber composition obtained by blending, into 100 parts by weight of a rubber, 10 to 100 parts by weight of carbon black surface-treated with a silane compound having an amino group (or groups), wherein at least 0.1 part by weight of the rubber ingredient is modified with maleic anhydride, whereby the heat buildup resistance and abrasion resistance of the rubber composition are enhanced and the scorch resistance is improved.

Abstract: In methods of preparing asphalt and elastomeric polymer compositions crosslinked with phenol aldehyde resins and sulfur, such as polymer modified asphalt (PMA), it has been discovered that the MP1 compatibility may be improved by adding certain ionic metal oxides. Suitable ionic metal oxides include, but are not necessarily limited to, zinc oxide, cadmium oxide, and the like. Acceptable elastomeric polymers include, but are not necessarily limited to, styrene-butadiene copolymers. Additional sulfur-containing crosslinkers may also be used.

Abstract: A rubber composition comprises 0.1-10 parts by mass of at least one of non-ionic surfactants having a special structure based on 100 parts by mass of at least one rubber component selected from natural rubber and synthetic diene rubbers.

Abstract: Flavan-based and spirodichroman compound-based phosphate esters prepared by reacting flavans and spirodichroman compounds with phosphorus oxychloride, monophenyl dichlorophosphate, or diphenyl chlorophosphate compounds are described. The flavans and spirodichroman compounds can be synthesized by the reaction of resorcinol with aliphatic acetone. Such phosphate esters can be used as flame retardants.

Abstract: The flameproof styrenic resin composition according to the present invention comprises (A) about 70 to 99.5 parts by weight of a rubber-modified polystyrene resin and (B) about 0.

Abstract: An anti-reflective coating film is formed by applying on a chemically amplified photoresist film an anti-reflective coating composition comprising an alkali-soluble fluorine-containing polymer, an acid, an amine and a solvent capable of dissolving these components and having a pH of 7 or less. The formed anti-reflective coating film can serve to prevent multiple reflections within the photoresist film, increase the amount of reduction in thickness of the photoresist film upon development with a developer after exposure, and form a pattern having a rectangular cross-sectional pattern and not having T-top or round top.

Abstract: Disclosed are articles of manufacture comprising ionomeric copolymers blended with organic acids or salts thereof that have a unique combination of high stiffness and resilience. Articles of manufacture according the invention include, without limitation, footwear structural components (e.g., heel counters, toe puffs, and soles), golf club components, and industrial applications (e.g., materials such as caulking materials, sealants, modifiers for cement and asphalt, coatings, packaging films, molded parts, and resilient foams for sporting goods).

Abstract: An ethylene polymer composition having improved optical properties and masterbatch for producing the composition comprising a predetermined amount of clarifying agent, and a predetermined amount of an amide slip agent.

Abstract: A polymer assisted deposition process for deposition of metal oxide films is presented. The process includes solutions of one or more metal precursor and soluble polymers having binding properties for the one or more metal precursor. After a coating operation, the resultant coating is heated at high temperatures to yield metal oxide films. Such films can be epitaxial in structure and can be of optical quality. The process can be organic solvent-free.

Abstract: The present invention provides a rubber composition for a tire capable of improving gripping performance of a tire and a tire using the rubber composition. More specifically, the present invention relates to a rubber composition for a tire tread comprising 1 to 150 parts by weight of a piezoelectric material, based on 100 parts by weight of a natural rubber and/or a diene synthetic rubber and a tire using the rubber composition for a tire tread. The average particle size of the piezoelectric material is preferably 0.01 to 50 ?m.

Abstract: A polymer composite and a stretched product thereof formed from a three dimensional network structure including an organic polymer (A), comprising either a polymer produced from a water soluble (meth)acrylate ester (a), or a copolymer of a water soluble (meth)acrylate ester (a) and at least one compound selected from a group consisting of (meth)acrylamide and N-substituted (meth)acrylamides (b), and a water swelling clay mineral (B).

Abstract: A low cost method of fabricating bipolar plates for use in fuel cells utilizes a wet lay process for combining graphite particles, thermoplastic fibers, and reinforcing fibers to produce a plurality of formable sheets. The formable sheets are then molded into a bipolar plates with features impressed therein via the molding process. The bipolar plates formed by the process have conductivity in excess of 150 S/cm and have sufficient mechanical strength to be used in fuel cells. The bipolar plates can be formed as a skin/core laminate where a second polymer material is used on the skin surface which provides for enhanced conductivity, chemical resistance, and resistance to gas permeation.

Abstract: A fluoroelastomer composition, which comprises 100 parts by weight of vinylidene fluoride-perfluoro(methyl vinyl ether)-tetrafluoroethylene terpolymer or vinylidene fluoride-hexafluoropropene copolymer, and 10-50 parts by weight of liquid fluoroelastomer having a viscosity of 500 to 3,000 cps at 100° C., can be made cross-linkable or vulcanizable fluoroelastomer composition upon further addition of 0.5 to 5 parts by weight of an organic peroxide and 0.5 to 10 parts by weight of a polyfunctional unsaturated compound or further addition of 0.5 to 10 parts by weight of a polyol-based vulcanizing agent thereto. The fluoroelastomer composition can give a cross-linked or vulcanized product having a hardness (Durometer A) of not more than 50 and distinguished processability and compression set resistance characteristics.

Abstract: Thermoplastic polymer compositions, films, continues, closures, laminates can comprise a modified vinyl polymer said modified polymer having a moiety comprising a cyclodextrin compound. The cyclodextrin compound, locked into the polymer structure, can absorb impurities, permeants, or other undesirable volatile materials. The cooperation between the cyclodextrin grafted onto the thermoplastic polymer and the polymer structure can provide barrier properties to a film, web or other polymer structure. A permeant or a contaminant can be complexed or trapped within the polymer and held within the film or Web preventing the permeant or contaminant from passing into the interior of a container or enclosure.

Abstract: A polymer blend consisting essentially of at least one thermoplastic polymer, and a polymer comprising structural units derived from a 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine is disclosed.

Abstract: A thermoplastic composition, comprising: about 10 to about 84 wt. % of a polycarbonate resin; about 0.5 to about 40 wt. % of a polycarbonate-polysiloxane copolymer; 1 to about 40 wt. % of an impact modifier composition; and about 1 to about 50 wt. % of an alkyl (meth)acrylate polymer; each based on the total combined weight of the thermoplastic composition, exclusive of any filler. In another embodiment, the thermoplastic composition may comprise about 10 to about 85 wt. % of a polycarbonate resin; about 1 to about 40 wt. % of an impact modifier composition; and about 1 to about 50 wt. % of an impact-modified alkyl (meth)acrylate polymer; each based on the total combined weight of the thermoplastic composition, exclusive of any filler. The compositions have improved weld line strength, and are useful in the manufacture of molded parts, especially for electronic devices.

Abstract: A shaped medical device article prepared from a polymer melt composition comprising a polymer ester, a transesterification catalyst, and a tri- or tetraalkoxy silane, by forming and solidifying said composition, and after solidification, subjecting the composition to reaction conditions to effect hydrolysis at least some alkoxysilyl groups remaining in the composition to form silanol groups and to effect condensation of said silanol groups to form a ceramic network. The polymer ester may be a vinyl ester homopolymer or copolymer, or a polymer having ester groups in the backbone thereof.

Abstract: A process for efficiently preparing polymer conjugates such as branched PEG-polypeptide conjugates, in large scale without column chromatography clean up of the activated PEG linkers to remove impurities is disclosed.